Ascend Capital’s Pfizer PFE Stock Holding History

Ascend Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$1.14M	Buy	+27,174	New	+$1.05M	0.06%	142
2017 Q4	–	Sell	-67,566	Closed	-$2.29M	–	238
2017 Q3	$2.29M	Sell	67,566 -1,006,132	-94%	-$32.3M	0.09%	136
2017 Q2	$34.2M	Buy	+1,073,698	New	+$33.9M	1.59%	14
2017 Q1	–	Sell	-562,194	Closed	-$17.3M	–	171
2016 Q4	$17.3M	Sell	562,194 -389,130	-41%	-$11.9M	0.86%	42
2016 Q3	$30.6M	Buy	951,324 +393,218	+70%	+$13.1M	1.87%	10
2016 Q2	$18.6M	Buy	558,106 +136,506	+32%	+$4.36M	1.22%	27
2016 Q1	$11.9M	Sell	421,600 -597,232	-59%	-$17.1M	1.13%	33
2015 Q4	$31.2M	Buy	1,018,832 +486,352	+91%	+$15.3M	1.1%	26
2015 Q3	$15.9M	Buy	532,480 +293,768	+123%	+$9.42M	0.62%	53
2015 Q2	$7.59M	Buy	+238,712	New	+$7.78M	0.25%	105
2015 Q1	–	Sell	-828,287	Closed	-$24.5M	–	202
2014 Q4	$24.5M	Sell	828,287 -1,699,756	-67%	-$48.7M	0.94%	38
2014 Q3	$70.9M	Buy	2,528,043 +136,048	+6%	+$3.82M	2.1%	3
2014 Q2	$67.4M	Buy	+2,391,995	New	+$68.2M	2.24%	6
2013 Q4	–	Sell	-387,656	Closed	-$10.6M	–	222
2013 Q3	$10.6M	Sell	387,656 -1,455,728	-79%	-$39.6M	0.39%	86
2013 Q2	$49M	Buy	+1,843,384	New	+$50.9M	2.08%	8

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ascend Capital's PFE Position: Q3 2018 in Review

Ascend Capital opened a new position in Pfizer (PFE) in Q3 2018: 27,174 shares worth $1.14M. The stake represents 0.06% of the portfolio and ranks #142 among its holdings. This is a return to the name: Ascend Capital previously reported a position in PFE as recently as Q3 2017.

Ascend Capital first reported a position in PFE in Q2 2013 and has held it in 15 quarters since. The position peaked at $70.9M in Q3 2014. 2,256 funds tracked by Wall St. Rank hold PFE as of Q3 2018.

Ascend Capital held 27,174 shares of Pfizer worth $1.14M as of Q3 2018.
Pfizer was a new Ascend Capital position in Q3 2018.
Pfizer made up 0.06% of Ascend Capital's portfolio in Q3 2018, its #142 holding.
Ascend Capital first reported a position in Pfizer in Q2 2013 and has held it in 15 quarters since.
Ascend Capital's Pfizer position peaked at $70.9M in Q3 2014.
2,256 funds tracked by Wall St. Rank held Pfizer as of Q3 2018.

Based on Ascend Capital's 13F filing for Q3 2018, filed 13 Nov 2018.